Form 4: Sotera Health Director Vincent Petrella Receives 19,132 Restricted Stock Units

Sotera Health Co. Director Vincent K. Petrella was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of his compensation, increasing his total beneficial ownership to 80,781 shares.

Summary

• Vincent K. Petrella, a Director of Sotera Health Co. (SHC), acquired 19,132 shares of Common Stock on May 22, 2025.
• These shares were granted as Restricted Stock Units (RSUs) with a price of $0, indicating they are part of an incentive plan.
• The RSUs will vest in full on the earlier of May 22, 2026 (the first anniversary of the grant date) or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on his continued service as a non-employee director.
• Following this transaction, Mr. Petrella's total beneficial ownership in Sotera Health Co. is 80,781 shares, comprising 19,132 RSUs and 61,649 shares of Common Stock.

Sentiment

Score: 7

Explanation: The document reports a routine equity grant to a director, which is a positive sign of alignment between management/board and shareholders, but does not contain significant new financial or operational news to warrant a higher score. It's a standard compensation event.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value.
• The grant is part of the company's 2020 Omnibus Incentive Plan, indicating a structured approach to executive and director compensation.

Risks

• The vesting of the RSUs is subject to the director's continued service as a non-employee director, meaning the full value is contingent on his ongoing tenure.

Future Outlook

The RSUs are subject to future vesting conditions, linking the director's compensation to future service and potentially future company performance.

Industry Context

This transaction represents a standard compensation practice for non-employee directors in publicly traded companies, aligning their interests with shareholders. It reflects the company's ongoing use of equity-based incentive plans to attract and retain board talent.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to non-employee directors is a common practice in the U.S. public company landscape, aligning director incentives with long-term shareholder value.
• The vesting schedule, tied to either the first anniversary or the next annual meeting, is typical for director equity grants, ensuring continued engagement.
• The use of an 'Omnibus Incentive Plan' is standard for broad-based equity compensation programs across various industries, including healthcare services and sterilization, which Sotera Health operates in.

Corporate Governance

Related Party Transactions

• The RSU grant is a transaction between the company and a director, which is a standard related party compensation mechanism disclosed as part of the company's incentive plan.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with shareholders, as the value of the RSUs is tied to the company's stock performance.

Next Steps

• The RSUs will vest on the earlier of May 22, 2026, or the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to continued service.

Key Dates

Recommendation

Keywords

Sotera Health, SHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Beneficial Ownership, Equity Grant, Incentive Plan